New HealthVerity taXOnomy dataset combines RWD claims to advance pharmaceutical research

HealthVerity launches taXOnomy, a dataset combining closed and open claims to enhance pharmaceutical research with detailed patient insights.

HealthVerity, a leader in integrating real-world data (RWD) with advanced technologies, has introduced HealthVerity taXOnomy, a comprehensive dataset designed to enhance pharmaceutical research. This new offering combines both closed (X) and open (O) claims data to provide detailed insights into patient journeys, supporting various applications across the drug lifecycle.

HealthVerity taXOnomy represents a significant advancement in the analysis and understanding of patient data. By incorporating both closed and open claims, the dataset offers a more complete view of patient experiences, often identifying 25% to 65% more patients than previous solutions. This broader perspective is increasingly critical in today’s healthcare environment, where there is a growing demand for complex and personalized medications.

The taXOnomy dataset builds on HealthVerity’s previous closed claims-focused solution, now expanded to cover hundreds of millions of patient lives. This integration offers a unified view of the payer and physician landscape, enabling pharmaceutical companies to accelerate commercial insights, identify optimal clinical trial sites, recruit appropriate patients, and develop real-world evidence more effectively.

Andrew Kress, CEO of HealthVerity, emphasized the significance of this new dataset:

“At HealthVerity, we are dedicated to bringing the life sciences industry the most robust data solutions in a frictionless manner, fundamentally enabling better patient outcomes. Our life sciences clients have been advantaged by our groundbreaking closed claims dataset, taXonomy, and have been asking us to assemble the unparalleled coverage, accuracy, and interoperability that only HealthVerity taXOnomy can deliver for challenges across the drug development and treatment lifecycle.”

A key aspect of HealthVerity taXOnomy is its HIPAA-compliant, privacy-protected design, which ensures that patient data is managed with the highest standards of security and confidentiality. The dataset is fully interoperable with lab results, electronic medical records, and hospital chargemaster data, helping to fill critical gaps in care and providing additional insights into diagnoses, procedures, lab results, and treatments. This interoperability allows for seamless integration with the nation’s largest healthcare and consumer data ecosystem, further enhancing its value for research and commercial purposes.

HealthVerity taXOnomy is updated daily with new payer information, providing pharmaceutical companies with access to current data. This regular updating process supports efficient reporting and informed decision-making, offering a streamlined, research-ready dataset that aligns with the standards of the pharmaceutical industry.